Tech Company Financing Transactions
Ascendant Dx Funding Round
On 5/20/2014, Ascendant Dx landed $2 million in funding from private investors.
Transaction Overview
Company Name
Announced On
5/20/2014
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds will help the biotech firm carry out clinical trials and commercialization of its early breast cancer detection test.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1200 Stewart Pl.
Springdale, AR 72764
USA
Springdale, AR 72764
USA
Phone
Website
Email Address
Overview
Our mission is to commercialize disruptive diagnostic technologies to aid in diagnosis and treatment of diseases of women and children.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Omid Moghadam
Chief Medical Officer
Suzanne Klimberg
Chief Scientific Officer
Anna Daily
Browse more venture capital transactions:
Prev: 5/20/2014: Sumo Logic venture capital transaction
Next: 5/21/2014: ecovent venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs